作者: insolence 時(shí)間: 2025-3-21 20:57
The Role of Hypoxia and Hyperthermia in Chemotherapy,ns of the tumor with regions where the oxygen concentration is significantly lower than in healthy tissues. Hypoxic tumor cells are usually resistant to chemotherapy and radiotherapy, but they can be made more susceptible to treatment by increasing the amount of oxygen in them. Cancer physiology can be a new significant target for therapy.作者: COLON 時(shí)間: 2025-3-22 00:51 作者: eustachian-tube 時(shí)間: 2025-3-22 04:40
Karl Reinhard Aigner,Frederick O. StephensDescribes the applications of induction chemotherapy in different cancer types.Presents integrated treatment practices used in various renowned institutions.Devotes detailed attention to pioneering an作者: 大炮 時(shí)間: 2025-3-22 10:07 作者: NICHE 時(shí)間: 2025-3-22 16:23 作者: 并入 時(shí)間: 2025-3-22 17:31 作者: BOLUS 時(shí)間: 2025-3-23 00:03
Frederick O. Stephenstion must be in the right form to be routed properly, to be handled without congestion, and to be understood at various points in the network. As for the computer scientist, he finds that his discipline has also changed. The fraction of computers that belong to networks is increasing all the time. And for a t978-1-4612-8093-4978-1-4613-0809-6作者: Terminal 時(shí)間: 2025-3-23 01:46
Maurie Markmanbe in the right form to be routed properly, to be handled without congestion, and to be understood at various points in the network. As for the computer scientist, he finds that his discipline has also changed. The fraction of computers that belong to networks is increasing all the time. And for a t作者: Gerontology 時(shí)間: 2025-3-23 06:42 作者: 改進(jìn) 時(shí)間: 2025-3-23 10:35
Miriam R. Habib,David L. Morrisr object attributes as a consequence of access have not been systematically studied. In this paper we motivate the need for usage control, define a family of ABC models as a core model for usage control and show how it encompasses traditional access control, such as mandatory, discretionary and role作者: FLIP 時(shí)間: 2025-3-23 15:36 作者: BUCK 時(shí)間: 2025-3-23 18:57
Induction Chemotherapy for Breast Cancer,r patients undergoing induction chemotherapy is the combination of an anthracycline (doxorubicin or epirubicin) + cyclophosphamide ± 5-FU followed by taxanes (weekly paclitaxel or docetaxel). For patients who cannot receive anthracycline therapy, docetaxel in combination with cyclophosphamide is a g作者: CANON 時(shí)間: 2025-3-24 01:40 作者: 滲透 時(shí)間: 2025-3-24 05:37 作者: 惡臭 時(shí)間: 2025-3-24 09:41
Induction Bidirectional Chemotherapy for Gastric Cancer with Peritoneal Dissemination, % with a median survival of 20.4 months. Gastrectomy with peritonectomy to eliminate all visible evidence of disease after a response to induction bidirectional chemotherapy should be considered in patients with primary gastric cancer and carcinomatosis.作者: neologism 時(shí)間: 2025-3-24 13:30
Gastric Cancer,al surgery..In cases of more advanced disease, induction chemotherapy can render inoperable tumors resectable. Other advantages of induction therapy include the ability to obtain information about tumor response, which can be used to study the biologic effects of chemotherapy and assess long-term di作者: nugatory 時(shí)間: 2025-3-24 15:09 作者: Nutrient 時(shí)間: 2025-3-24 20:23
Induction Chemotherapy for Hepatocellular Carcinoma,ional chemotherapy of the liver. The phase I study of PIHP for advanced HCC showed favorable treatment results. Currently, phase II and III trials for HCC are taking place in the United States as a multicenter study..During the last decade, many molecular targeted agents have been researched in clin作者: Cupping 時(shí)間: 2025-3-25 02:14 作者: insipid 時(shí)間: 2025-3-25 06:40
Book 2016Latest editionde to administer chemotherapeutics via the arterial route in order to achieve higher localized drug exposure and response rates. Such therapies are being practiced worldwide in independent, remote departments in universities, teaching hospitals and clinical schools. Frequently, however, these teams 作者: 口訣法 時(shí)間: 2025-3-25 11:08
Miriam R. Habib,David L. Morris, and administrative goals in an integrated manner. It is an essential security resource for undergraduate or graduate study, practitioners in networks, and professionals who develop and maintain secure computer network systems.978-1-4419-3543-4978-0-387-25228-5作者: LIKEN 時(shí)間: 2025-3-25 12:36 作者: nutrients 時(shí)間: 2025-3-25 17:44
Adorján F. Kovács, and administrative goals in an integrated manner. It is an essential security resource for undergraduate or graduate study, practitioners in networks, and professionals who develop and maintain secure computer network systems.978-1-4419-3543-4978-0-387-25228-5作者: 苦笑 時(shí)間: 2025-3-25 23:31
Karl Reinhard Aigner MD,Emir Selak,Rita Schlaf, and administrative goals in an integrated manner. It is an essential security resource for undergraduate or graduate study, practitioners in networks, and professionals who develop and maintain secure computer network systems.978-1-4419-3543-4978-0-387-25228-5作者: 血統(tǒng) 時(shí)間: 2025-3-26 02:06 作者: 貨物 時(shí)間: 2025-3-26 06:06 作者: Obituary 時(shí)間: 2025-3-26 11:17
Karl Reinhard Aigner MD,Stefano Guadagni,Giuseppe Zavattieri, and administrative goals in an integrated manner. It is an essential security resource for undergraduate or graduate study, practitioners in networks, and professionals who develop and maintain secure computer network systems.978-1-4419-3543-4978-0-387-25228-5作者: Canopy 時(shí)間: 2025-3-26 16:22 作者: 相反放置 時(shí)間: 2025-3-26 19:13
Y. Yonemura,Paul H. Sugarbaker, and administrative goals in an integrated manner. It is an essential security resource for undergraduate or graduate study, practitioners in networks, and professionals who develop and maintain secure computer network systems.978-1-4419-3543-4978-0-387-25228-5作者: 暗語(yǔ) 時(shí)間: 2025-3-26 21:33
Tetsuo Taguchi, and administrative goals in an integrated manner. It is an essential security resource for undergraduate or graduate study, practitioners in networks, and professionals who develop and maintain secure computer network systems.978-1-4419-3543-4978-0-387-25228-5作者: V洗浴 時(shí)間: 2025-3-27 01:33
Tetsuo Taguchi, and administrative goals in an integrated manner. It is an essential security resource for undergraduate or graduate study, practitioners in networks, and professionals who develop and maintain secure computer network systems.978-1-4419-3543-4978-0-387-25228-5作者: 半身雕像 時(shí)間: 2025-3-27 06:00 作者: Expressly 時(shí)間: 2025-3-27 12:48 作者: 阻礙 時(shí)間: 2025-3-27 17:13 作者: Cosmopolitan 時(shí)間: 2025-3-27 19:31 作者: machination 時(shí)間: 2025-3-27 23:34 作者: exhibit 時(shí)間: 2025-3-28 04:33
Cryotherapy,the most frequent use of cryotherapy is in the treatment of dermatological lesions, but it now has an established role in the treatment of other malignancies including those of the prostate, kidney, liver, cervix, bone and eyes. This chapter outlines the rationale behind this system and its role in current cancer treatment.作者: 或者發(fā)神韻 時(shí)間: 2025-3-28 06:29
Isolated Thoracic Perfusion with Carotid Artery Infusion for Advanced and Chemoresistant Tumors of n 7 min in an isolated thoracic perfusion circuit seems to generate superior response rates. In two patients with systemically pretreated and nonresponding bulky high-volume cancers of the parotid gland, isolated thoracic perfusion with carotid artery infusion led to substantial tumor shrinkage and local resectability.作者: 幻影 時(shí)間: 2025-3-28 14:11 作者: Magnitude 時(shí)間: 2025-3-28 15:16
Induction Chemotherapy in Head and Neck Cancers,ts in the treatment for regionally advanced and recurrent cancers and should be considered as preoperative induction treatment in management of resectable cancers of the oral cavity and anterior oropharynx.作者: Neuralgia 時(shí)間: 2025-3-28 21:36
Esophageal Cancer,cancer. A three-way study is needed to compare results of preoperative schedules of induction chemotherapy alone (intra-arterial and systemic) with chemoradiation as preoperative induction treatment for advanced esophageal cancer.作者: Narcissist 時(shí)間: 2025-3-29 01:38
Local and Regional Hyperthermia,e focus or regionally in an extremity or body cavity. Its usefulness stems from its ability to damage malignant cells whilst relatively sparing normal tissues and from its synergism with chemotherapy and radiotherapy. This chapter describes the rationale and uses for local and regional hyperthermia in the treatment of malignant disease.作者: 地牢 時(shí)間: 2025-3-29 05:34 作者: 假裝是你 時(shí)間: 2025-3-29 11:06
Drug Removal Systems and Induction Chemotherapy,nation of regional therapies plus surgery can be essential in promoting improved patient outcomes. However, recent reports suggest that regional chemotherapy used in a neoadjuvant setting followed by curative surgery yield the best long-term results. Sequentially, the addition of adjuvant chemotherapy further improves patient outcomes.作者: orthodox 時(shí)間: 2025-3-29 15:25 作者: 生銹 時(shí)間: 2025-3-29 18:48 作者: 刻苦讀書 時(shí)間: 2025-3-29 21:29
Introduction: Overview, History, Terminology and Early Clinical Experience,blative surgery without general anaesthesia, it was not until the discovery of general anaesthesia in the mid-nineteenth century that modern operative surgery, as we know it, could be developed. Thus, safe and painless operative surgery developed as the first significant advance in cancer treatment.作者: OCTO 時(shí)間: 2025-3-30 00:57
The Principle of Dose Response in Antineoplastic Drug Delivery,sity improves outcome (e.g., acute leukemia), but in most solid tumors, optimal scheduling of drug delivery appears to be at least as important in defining outcome as the dose administered. In fact, several phase 3 randomized trials have failed to demonstrate a favorable impact on survival of “high-作者: 植物茂盛 時(shí)間: 2025-3-30 05:31 作者: MOTTO 時(shí)間: 2025-3-30 10:56 作者: 漂亮 時(shí)間: 2025-3-30 14:31 作者: organism 時(shí)間: 2025-3-30 17:42
The Role of Hypoxia and Hyperthermia in Chemotherapy,ns of the tumor with regions where the oxygen concentration is significantly lower than in healthy tissues. Hypoxic tumor cells are usually resistant to chemotherapy and radiotherapy, but they can be made more susceptible to treatment by increasing the amount of oxygen in them. Cancer physiology can作者: 神化怪物 時(shí)間: 2025-3-30 23:34 作者: Albumin 時(shí)間: 2025-3-31 02:41
Isolated Thoracic Perfusion with Carotid Artery Infusion for Advanced and Chemoresistant Tumors of large variety of locoregional modes of drug administration have been reported so far, ranging from intra-arterial long-term infusion to superselective supradose infusion or chemoembolization, the short-term exposure of high concentrations of cytotoxics by means of intra-arterial infusion over media作者: 地殼 時(shí)間: 2025-3-31 05:37
Induction Chemotherapy for Breast Cancer,cer (LABC) and patients with stage II–III disease in order to downstage the tumour burden and ensure appropriate breast conservation. Induction therapy treatment also makes it possible to evaluate drug sensitivity. The achievement of tumour and nodal pathological complete remission (pCR) or minimal 作者: Precursor 時(shí)間: 2025-3-31 09:27 作者: ARY 時(shí)間: 2025-3-31 14:32
Regional Chemotherapy for Thoracic Wall Recurrence and Metastasized Breast Cancer,s were indicated, such as mastectomy and inclusion of the pectoralis major muscle, the treatment standards have changed increasingly from initially mastectomy alone toward breast-conserving measures. Radical surgical interventions are considered local overtreatment. Similarly, the primary axillary d作者: 季雨 時(shí)間: 2025-3-31 18:57
Induction Bidirectional Chemotherapy for Gastric Cancer with Peritoneal Dissemination,py prior to a major surgical exploration. From the data available in the literature, the surgeon is forced to make a judgment concerning the risks and benefits of an aggressive management plan versus supportive care. A strategy has evolved that utilizes induction intravenous and intraperitoneal chem
